All Ords Hits Record High Above 9,400 as ASX 200 Tests 9,200 Level

Aussie markets powered to fresh all-time highs today, with the All Ords Index cracking through the psychologically significant 9,400 barrier and the ASX 200 testing 9,200, as strong corporate earnings in healthcare and technology sectors fuelled a broad-based rally that saw both benchmark indices close more than half a percent higher.

The All Ordinaries index reached an intraday, and new all time high of 9,436.10 before settling 0.53% higher at 9,408.70, marking a decisive close above the 9,400 level that had previously offered resistance in earlier attempts. The ASX 200 mirrored this strength, advancing 0.51% to 9,175.30 after testing the 9,200 threshold during the session.

ASX 200 Leaders and Laggards

Healthcare stocks dominated the leaderboard, with Telix Pharmaceuticals shares (TLX) surging 10.87% to $10.20, while Ramsay Health Care (RHC) jumped 10.35% to $42.12. The technology sector provided additional momentum, as Pro Medicus (PME) climbed 9.78% to $127.60 and cloud accounting provider Xero (XRO) gained 8.63% to $82.30 to continue a two day bounce. Defence contractor DroneShield (DRO) added 8.85% to reach $3.69, while Super Retail Group (SUL)  and Perpetual (PPT) rounded out the top performers with gains of 8.39% and 8.34% respectively.

The session’s weakness concentrated in the resources and industrial sectors.

Engineering firm Worley shares (WOR) plunged 10.2% to $11.71, while Qantas Airways (QAN) tumbled 9.2% to $9.67. Lithium miner Liontown (LTR) fell 8.56% to $1.815, and coal producers Yancoal Australia (YAL) and Stanmore Resources (SMR) declined 8.44% and 6.88% respectively, reflecting broader headwinds facing the commodities complex.

Driving Shares On The Day

Ramsay Health Care delivered one of the session’s standout earnings reports, posting revenue growth of 9.7% to $9.34 billion alongside an 8.1% increase in underlying net profit after tax to $171.7 million. The hospital operator’s Australian business drove the strong performance, demonstrating resilience in its core domestic market despite ongoing pressures in the healthcare sector.

Pro Medicus continued its impressive growth trajectory, with markets responding enthusiastically to increased adoption of the company’s medical imaging software solutions. The result reflected accelerating demand for digital healthcare infrastructure, a theme that has underpinned the stock’s remarkable performance over recent years.

Xero reported a 20% expansion in its subscriber base, underscoring the continued shift toward cloud-based accounting solutions among small and medium-sized businesses. The subscriber growth translated directly into higher recurring revenues, reinforcing the company’s position as a dominant player in its market segment.

On the downside, Worley’s 5.4% revenue increase to $6.31 billion was overshadowed by $82 million in restructuring charges that weighed on profitability. Markets reacted negatively to the one-off costs, which raised questions about the engineering firm’s operational efficiency and strategic direction.

Qantas faced a sharp sell-off despite reporting underlying profit before tax of $1.456 billion. Rising operational costs emerged as a key concern, with markets questioning whether the national carrier can maintain margins in an environment of elevated fuel prices and wage pressures.

DroneShield’s strong performance followed the announcement of a significant defence contract, highlighting growing demand for counter-drone technology amid heightened security concerns. The contract win positions the company for sustained revenue growth as governments worldwide prioritise aerial threat detection capabilities.

In Short

The record highs achieved by both the All Ordinaries and ASX 200 reflect a market environment characterised by selective strength rather than uniform gains. Technical indicators point to continued momentum in the headline indices, with the All Ordinaries’ decisive close above 9,400 potentially opening the path toward 9,500. The ASX 200’s test of 9,200 suggests buyers remain willing to support the market at current levels, though overbought conditions may warrant caution.

Thursday’s session delivered a clear verdict: markets continue to reward companies demonstrating earnings growth and strategic execution while punishing those facing cost pressures or missing expectations, with the record highs masking significant sector-level divergence that suggests selectivity will remain paramount as 2026 progresses.